Effect of Rosiglitazone

• Status: Completed
• Trial end date: 2004-11-01
• Target enrollment: 0
• Participant gender: Male

Summary

To evaluate :

• acute effects of a single dose of 8 mg rosiglitazone (therapeutic dose)

• on insulin secretion and

• insulin sensitivity in 12 healthy male subjects.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University Hospital, Montpellier
• Treatments: Rosiglitazone

Criteria

Inclusion Criteria:

• BMI between 18.0 and 24.0

Exclusion Criteria:

-